Centessa Pharmaceuticals

IPO

Homepage

Public · United States · Founded 2021 · $550.0M raised

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$550.0M
Last Round
$300.0M Corporate RoundApr 2024
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Centessa Pharmaceuticals is a clinical-stage biopharmaceutical company built on an asset-centric R&D model, formed through the merger of multiple biotech companies to pursue first-in-class and best-in-class medicines. Its pipeline spans discovery-stage to late-stage programs in neuroscience, including an orexin receptor 2 (OX2R) agonist program for sleep-wake disorders and its proprietary LockBody antibody technology platform. In 2026 Centessa agreed to be acquired by Eli Lilly and Company for up to $7.8 billion.

Summary

Centessa Pharmaceuticals is a Healthcare company based in United States, founded in 2021. It has raised $550.0M in total across 2 rounds, most recently a $300.0M Corporate Round in Apr 2024. Investors include General Atlantic and EcoR1 Capital.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Corporate RoundCorporate RoundApr 2024
$300.0M

Sign up to see all 3 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021
Oscar HealthIPO

Oscar Health uses technology to deliver simple, personalized health insurance and member-care exp...

New York, United States1001–5000Healthcare, Insurance
ConvertibleTotal funding$1.8BOct 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Centessa Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/centessa-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/centessa-pharmaceuticals" alt="Centessa Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>